Copper rose above $9,000 a metric ton for the first time in nine years, taking another step closer to an all-time high set in 2011 as investors bet that supply tightness will increase as the world recovers from the pandemic.
Copper Surges Above $9,000 as Shortfall Concern Spurs Rally
Copper rose above $9,000 a metric ton for the first time in nine years, taking another step closer to an all-time high set in 2011 as investors bet that supply tightness will increase as the world recovers from the pandemic.
Gold price gains amid positive outside market forces
(Kitco News) - Gold futures prices are solidly higher in early U.S. trading Monday and have rebounded after hitting an eight-month Friday.
New Study Suggests Link Between Cannabis Legalization And Decline In Workers Comp Claims
A new research paper from the National Bureau of Economic Research suggests a connection between marijuana legalization and a decline in workers’ compensation claims.
Mind Cure Announces Addition of Global Technology Leader Robert C. Hill to Board of Directors
MINDCURE's new Director is a veteran of capital markets.
Vermont Lawmakers Prepare Psychedelics And Broader Drug Decriminalization Bills For Introduction
Vermont lawmakers plan to introduce at least two bills this legislative session to decriminalize the possession of drugs, with one of those proposals expected early next week.
Proposed California Psychedelics Bill Would Be Sector Turning Point
California's new proposed psychedelics "decriminalization" would, in fact, LEGALIZE possession of many psychedelic substances.
Copper price blasts to 9-year high on demand optimism
Copper prices jumped to a nine-year high on Thursday as Chinese investors returned from a week-long holiday, adding impetus to a rally that has almost doubled prices since the height of coronavirus worries last March.
Mining stocks climb as copper trades near decade high
Mining shares jumped on Thursday, getting a lift as copper futures rallied while broader European stock markets struggled for direction.
Mindset Pharma Added to North American Psychedelics Index
Toronto, Ontario-- Mindset Pharma Inc., a drug discovery and development company focused on developing next generation psilocybin-inspired medicines and related technologies, is pleased to announce that effective today, it has been added to the North American Psychedelics Index which is provided by German-based index provider, Solactive.
Can LSD cure our pandemic anxiety? MindMed is spending big to find out
While many people will look back on the pandemic as a dark time, it has also spurred some positive developments—most notably in the field of drug development, where miraculous breakthroughs like mRNA vaccines are transforming immunology.
MINDCURE’s Psychedelics R&D Targets Blockbuster TBI Treatment Market
MINDCURE's R&D on traumatic brain injury (TBI) targets the LARGEST individual market for psychedelic drugs.
